216 A NEW SELECTIVE SIGMA‐1 RECEPTOR ANTAGONIST (S1RA) REDUCES NEUROPATHIC PAIN BEHAVIORS AND ACTIVITY‐INDUCED SPINAL SENSITISATION | Publicación